256 related articles for article (PubMed ID: 15863234)
1. Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice.
Hiramatsu M; Hoshino T; Kanematsu K
Behav Brain Res; 2005 May; 160(2):374-81. PubMed ID: 15863234
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of the ameliorating effect on learning and memory impairment and antinociceptive effect of KT-95 in mice.
Hiramatsu M; Mizuno N; Kanematsu K
Behav Brain Res; 2006 Feb; 167(2):219-25. PubMed ID: 16223533
[TBL] [Abstract][Full Text] [Related]
3. Improvement of memory impairment by (+)- and (-)-pentazocine via sigma, but not kappa opioid receptors.
Hiramatsu M; Hoshino T
Brain Res; 2005 Sep; 1057(1-2):72-80. PubMed ID: 16125682
[TBL] [Abstract][Full Text] [Related]
4. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy.
Hiramatsu M; Hoshino T
Brain Res; 2004 Dec; 1030(2):247-55. PubMed ID: 15571673
[TBL] [Abstract][Full Text] [Related]
5. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
Itoh J; Ukai M; Kameyama T
J Pharmacol Exp Ther; 1994 Apr; 269(1):15-21. PubMed ID: 7909556
[TBL] [Abstract][Full Text] [Related]
6. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
8. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
9. Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice.
Sakaguchi M; Koseki M; Wakamatsu M; Matsumura E
Eur J Pharmacol; 2006 Jan; 530(1-2):81-7. PubMed ID: 16360145
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1993 Mar; 264(3):1021-7. PubMed ID: 7680715
[TBL] [Abstract][Full Text] [Related]
11. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice.
Shu H; Hayashida M; Arita H; Huang W; Zhang H; An K; Wu G; Hanaoka K
J Pharmacol Exp Ther; 2011 Aug; 338(2):579-87. PubMed ID: 21543510
[TBL] [Abstract][Full Text] [Related]
12. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
Zhao M; Wang JY; Jia H; Tang JS
Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
[TBL] [Abstract][Full Text] [Related]
13. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
Gairin JE; Gout R; Meunier JC; Cros J
J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
[TBL] [Abstract][Full Text] [Related]
14. Enkephalin derivative, cyclo[Nepsilon,Nbeta-carbonyl-D-Lys2, Dap5] enkephalinamide (cUENK6), induces a highly potent antinociception in rats.
Kotlinska J; Bochenski M; Lagowska-Lenard M; Gibula-Bruzda E; Witkowska E; Izdebski J
Neuropeptides; 2009 Jun; 43(3):221-8. PubMed ID: 19376576
[TBL] [Abstract][Full Text] [Related]
15. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
Reeta Kh; Mediratta PK; Rathi N; Jain H; Chugh C; Sharma KK
Regul Pept; 2006 Jul; 135(1-2):85-90. PubMed ID: 16712978
[TBL] [Abstract][Full Text] [Related]
16. Preventing morphine antinociceptive tolerance by irreversible mu opioid antagonists before the onset of their antagonism.
Jiang Q; Seyed-Mozaffari A; Sebastian A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1995 May; 273(2):680-8. PubMed ID: 7752070
[TBL] [Abstract][Full Text] [Related]
17. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
18. A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse.
Welch SP; Stevens DL; Dewey WL
J Pharmacol Exp Ther; 1992 Jan; 260(1):117-27. PubMed ID: 1346158
[TBL] [Abstract][Full Text] [Related]
19. Involvement of kappa-opioid and sigma receptors in short-term memory in mice.
Hiramatsu M; Hoshino T; Kameyama T; Nabeshima T
Eur J Pharmacol; 2002 Oct; 453(1):91-8. PubMed ID: 12393064
[TBL] [Abstract][Full Text] [Related]
20. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
